Health Policy
News from the FDA/CDC
Vape lung disease cases exceed 400, 3 dead
Vitamin E acetate is one possible culprit in the mysterious vaping-associated lung disease that has killed three patients, sickened 450, and...
News
FDA chief calls for release of all data tracking problems with medical devices
The FDA is “realizing that physicians who couldn’t see this data before were using devices that they wouldn’t have used if they had this data in...
From the Journals
AAP, AHA push for policies limiting children’s sugary beverage consumption
The new policy statement focuses on local, state, and federal policies that can discourage sugary beverage intake in addition to counseling...
Feature
FDA chief calls for stricter scrutiny of electronic health records
The government spent more than $36 billion over 10 years to switch to digital records. In that time, thousands of reports of deaths, injuries, and...
Conference Coverage
MedPAC puts Part B reference pricing, binding arbitration on the table
The reference pricing policy would set a maximum payment rate for a group of drugs with similar health effects based on the minimum, median, or...
From the Journals
Will patient rewards for lower-cost choices impact physicians?
The rewards program offered $25-$500 for making lower-cost choices across 131 elective services.
Sponsored Supplement
Improving Medication Adherence in Chronic Disease Management
Feature
Survey: Americans support regulation of vaping products
Despite FDA efforts under Commissioner Scott Gottlieb to raise awareness of teen vaping, only 21% of those surveyed correctly responded that e-...
Feature
Prior authorization an increasing burden
Insurers are not following the 2018 consensus statement on improving the prior authorization process, the AMA says.
Conference Coverage
Large survey reveals that few MS patients have long-term care insurance
DALLAS – The findings suggest that clinical care teams should initiate early discussions of possible long-term needs with their patients.
Latest News
Big pharma says it can’t drop drug list prices alone
The problem, they say, is the financial structure of drug delivery that ties list prices and their associated rebates to formulary placement.
Latest News
What does 'Medicare for all' mean?
Most respondents assumed that private insurance would be involved in some way.